Different associations between organ-specific immune-related adverse event and survival in non-small cell lung cancer patients treated with programmed death-1 inhibitors-based combination therapy

BACKGROUND: The profile of immune-related adverse events (irAEs) due to programmed death-1 (PD-1) inhibitors-based combination therapy in advanced non-small cell lung cancer (NSCLC) and its relationship with survival have not been fully described. OBJECTIVE: Designed to capture the spectrum of irAEs...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuzhong, Shi, Yuanjian, Ding, Hanlin, Feng, Yipeng, Zhang, Te, Liang, Yingkuan, Wang, Hui, Song, Xuming, Chen, Bing, Xia, Wenjie, Mao, Qixing, Shen, Bo, Xu, Lin, Dong, Gaochao, Jiang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644755/
https://www.ncbi.nlm.nih.gov/pubmed/38028145
http://dx.doi.org/10.1177/17588359231210678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644755/
https://www.ncbi.nlm.nih.gov/pubmed/38028145
http://dx.doi.org/10.1177/17588359231210678

Ejemplares similares